6-Imino-2-thioxo-pyrimidinones as a new class of dipeptidyl peptidase IV inhibitors

被引:2
|
作者
Jelic, Dubravko [1 ]
Nujic, Krunoslav [1 ]
Stepanic, Visnja [1 ]
Kovacevic, Krunoslav [1 ]
Verbanac, Donatella [1 ]
机构
[1] GlaxoSmithKline Res Ctr Zagreb Ltd, Zagreb 10000, Croatia
关键词
DPP IV inhibitor; Pyrimidinone; Enzyme kinetics; Molecular docking; Cytotoxicity; GENETIC ALGORITHM; VALIDATION; EXPRESSION; THERAPY; DOMAIN;
D O I
10.1007/s00044-010-9314-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dipeptidyl peptidase IV is a glycoprotein which removes N-terminal dipeptides from physiologically relevant polypeptides. An homologous series of 6-imino-2-thioxo-5-{[3,4,5-tris(methyloxy)phenyl]methyl}-2,5-dihydro-4(3H)-pyrimidinones has been tested for inhibition of DPP IV activity. The inhibitory effects at 0.1 mM were observed. Enzyme kinetic studies revealed that compounds inhibit DPP IV activity competitively. According to the molecular docking analysis, the inhibitors are anchored into the DPP IV hydrolytic site by interactions of the pyrimidinone core with Glu206, Tyr662, and Tyr547, with the alkyl chain entering the S1 pocket. We conclude that pyrimidinone-like compounds are a promising new scaffold for reversible inhibition of DPP IV.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 50 条
  • [41] Integration of Deep Learning and Sequential Metabolism to Rapidly Screen Dipeptidyl Peptidase (DPP)-IV Inhibitors from Gardenia jasminoides Ellis
    Liu, Huining
    Yu, Shuang
    Li, Xueyan
    Wang, Xinyu
    Qi, Dongying
    Pan, Fulu
    Chai, Xiaoyu
    Wang, Qianqian
    Pan, Yanli
    Zhang, Lei
    Liu, Yang
    MOLECULES, 2023, 28 (21):
  • [42] Neuropeptides, substrates and inhibitors of human dipeptidyl peptidase III, experimental and computational study - A new substrate identified
    Karacic, Zrinka
    Supljika, Filip
    Tomic, Antonija
    Brkljacic, Lidija
    Paic, Ana Tomasic
    Cehic, Mirsada
    Tomic, Sanja
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 220 : 1390 - 1401
  • [43] 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents
    Saqib, U.
    Siddiqi, M. I.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2009, 20 (5-6) : 519 - 535
  • [44] Design, Synthesis and Biological Evaluation of Spiro Cyclohexane-1,2-Quinazoline Derivatives as Potent Dipeptidyl Peptidase IV Inhibitors
    Syam, Yasmin M.
    Abd El-Karim, Somaia S.
    Nasr, Tamer
    Elseginy, Samia A.
    Anwar, Manal M.
    Kamel, Mohsen M.
    Ali, Hanan F.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 250 - 269
  • [45] Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients
    Yang, Chen-Yi
    Lin, Wei-Ann
    Su, Pei-Fang
    Li, Lun-Jie
    Yang, Chun-Ting
    Ou, Huang-Tz
    Kuo, Shihchen
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (03) : 772 - 781
  • [46] Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
    Devadas, Balekudru
    Selness, Shaun R.
    Xing, Li
    Madsen, Heather M.
    Marrufo, Laura D.
    Shieh, Huey
    Messing, Dean M.
    Yang, Jerry Z.
    Morgan, Heidi M.
    Anderson, Gary D.
    Webb, Elizabeth G.
    Zhang, Jian
    Devraj, Rajesh V.
    Monahan, Joseph B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (13) : 3856 - 3860
  • [47] Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus
    Wei, Xin
    Bai, Yu
    Wang, Zhuo
    Zheng, Xiaohong
    Jin, Zening
    Liu, Xin
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01)
  • [48] Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
    Rao, Praveen P. N.
    Pham, Amy Trinh
    Shakeri, Arash
    El Shatshat, Amna
    Zhao, Yusheng
    Karuturi, Rahul C.
    Hefny, Ahmed A.
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 16
  • [49] Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
    Li, Ning
    Wang, Li-Jun
    Jiang, Bo
    Li, Xiang-qian
    Guo, Chuan-long
    Guo, Shu-ju
    Shi, Da-Yong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 145 - 157
  • [50] In vitro metabolism and transport of the new dipeptidyl peptidase 4 inhibitors, KR66222 and KR66223
    Ahn, Hee Jeong
    Kim, Kwon-Bok
    Liu, Kwang-Hyeon
    Shin, Jae-Gook
    Ahn, Jin Hee
    Kim, Min-Sun
    Bae, Myung-Ae
    Song, Im-Sook
    XENOBIOTICA, 2011, 41 (06) : 445 - 455